About: Tenidap

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Tenidap was a COX/5-LOX inhibitor and cytokine-modulating anti-inflammatory drug candidate that was under development by Pfizer as a promising potential treatment for rheumatoid arthritis, but Pfizer halted development after marketing approval was rejected by the FDA in 1996 due to liver and kidney toxicity, which was attributed to metabolites of the drug with a thiophene moiety that caused oxidative damage.

Property Value
dbo:abstract
  • Tenidap was a COX/5-LOX inhibitor and cytokine-modulating anti-inflammatory drug candidate that was under development by Pfizer as a promising potential treatment for rheumatoid arthritis, but Pfizer halted development after marketing approval was rejected by the FDA in 1996 due to liver and kidney toxicity, which was attributed to metabolites of the drug with a thiophene moiety that caused oxidative damage. (en)
dbo:casNumber
  • 120210-48-2
dbo:chEMBL
  • 1097558
dbo:fdaUniiCode
  • 9K7CJ74ONH
dbo:kegg
  • D06072
dbo:pubchem
  • 60712
dbo:thumbnail
dbo:wikiPageID
  • 13590437 (xsd:integer)
dbo:wikiPageLength
  • 3894 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 964169695 (xsd:integer)
dbo:wikiPageWikiLink
dbp:atcPrefix
  • M01 (en)
dbp:atcSuffix
  • AX23 (en)
dbp:c
  • 14 (xsd:integer)
dbp:casNumber
  • 120210 (xsd:integer)
dbp:chembl
  • 1097558 (xsd:integer)
dbp:chemspiderid
  • 54717 (xsd:integer)
dbp:cl
  • 1 (xsd:integer)
dbp:h
  • 9 (xsd:integer)
dbp:iupacName
  • 5 (xsd:integer)
dbp:kegg
  • D06072 (en)
dbp:n
  • 2 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 60712 (xsd:integer)
dbp:s
  • 1 (xsd:integer)
dbp:smiles
  • c1ccCc2c3ccCl (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • IZSFDUMVCVVWKW-UHFFFAOYSA-N (en)
dbp:unii
  • 9 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 408923737 (xsd:integer)
dbp:watchedfields
  • changed (en)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Tenidap was a COX/5-LOX inhibitor and cytokine-modulating anti-inflammatory drug candidate that was under development by Pfizer as a promising potential treatment for rheumatoid arthritis, but Pfizer halted development after marketing approval was rejected by the FDA in 1996 due to liver and kidney toxicity, which was attributed to metabolites of the drug with a thiophene moiety that caused oxidative damage. (en)
rdfs:label
  • Tenidap (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License